HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Neurocognitive Therapy for Substance Use Disorders

Neurocognitive Therapy for Substance Use Disorders

Neurocognitive therapy is a therapeutic approach that addresses cognitive deficits commonly seen in individuals with substance use disorders. These deficits, such as problems with memory, attention, and executive function, often result from the chronic use of substances. Neurocognitive therapy aims to restore and enhance cognitive functioning through various exercises and techniques that promote brain plasticity. It may include cognitive retraining, memory exercises, and problem-solving tasks. By improving cognitive abilities, patients are better equipped to handle the challenges of addiction recovery, make informed decisions, and maintain long-term sobriety. This approach plays a key role in addressing the cognitive aspects of addiction and recovery.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John J Giordano

John J Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Tags

Submit your abstract Today

Whatsapp